Regulation of tissue factor expression in smooth muscle cells with nitric oxide

J Vasc Surg. 2003 Mar;37(3):650-9. doi: 10.1067/mva.2003.140.

Abstract

Objective: This study was undertaken to determine the effect of nitric oxide (NO) on tissue factor (TF) expression in vascular smooth muscle cells.

Study design: Rat aortic smooth muscle cells (RASMCs) were exposed to NO delivered exogenously with the NO donor S-nitroso-N-acetylpenicillamine (SNAP) or produced endogenously after infection with an adenoviral vector carrying human inducible NO synthase (AdiNOS). Functional TF activity was assessed with chromogenic TF assay. TF antigen was determined with immunohistochemistry. Northern blot analysis was used to determine steady- state TF messenger RNA (mRNA). Electrophoretic mobility gel shift assay was performed to determine the nuclear binding activity of nuclear factor kappa-B (NFkappaB). NFkappaB activity was inhibited by either prior transduction of RASMCs with mutant IkappaB or treatment with pyrrolidine dithiocarbamate.

Results: RASMCs exposed to SNAP or infected with AdiNOS exhibited increased functional TF activity and antigen. Regardless of the source of NO, a time-dependent and concentration-dependent increase in TF activity was observed. Steady-state TF mRNA levels were also increased by NO delivered via either method. NFkappaB nuclear binding activity was also increased by NO. Inhibition of NFkappaB activity by either pyrrolidine dithiocarbamate treatment or mutant IkappaB transduction abrogated NO-induced enhancement of TF mRNA and functional activity.

Conclusion: In RASMC, NO exposure results in upregulation of TF functional activity, antigen, and mRNA. This effect appears to be mediated by an NFkappaB-dependent pathway.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae
  • Animals
  • Antigens / metabolism
  • Aorta, Thoracic
  • Biological Assay
  • Blotting, Northern
  • Cells, Cultured
  • DNA / metabolism
  • Electrophoretic Mobility Shift Assay
  • Genetic Vectors
  • I-kappa B Proteins / genetics
  • I-kappa B Proteins / pharmacology
  • Immunohistochemistry
  • Male
  • Muscle, Smooth, Vascular / metabolism*
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Protein Binding
  • Pyrrolidines / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Thiocarbamates / pharmacology
  • Thromboplastin / genetics
  • Thromboplastin / immunology
  • Thromboplastin / metabolism*
  • Transfection
  • Up-Regulation

Substances

  • Antigens
  • I-kappa B Proteins
  • NF-kappa B
  • Nitric Oxide Donors
  • Pyrrolidines
  • RNA, Messenger
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • Nitric Oxide
  • S-Nitroso-N-Acetylpenicillamine
  • DNA
  • Thromboplastin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat